Role of nanotechnology in developing new therapies for diseases of the nervous system

ISSN： 1743-5889

Source： Nanomedicine, Vol.1, Iss.1, 2006-06, pp. : 9-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CNV and nervous system diseases – what’s new?

Cytogenetic and Genome Research, Vol. 123, Iss. 1-4, 2009-03 ,pp. : 54-64

Karger

Access to resources Recommend Favorite

Olfactory Pathology in Central Nervous System Demyelinating Diseases

BRAIN PATHOLOGY, Vol. 25, Iss. 5, 2015-09 ,pp. : 543-551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neurodegeneration and Aging of the Central Nervous System - implications for neurodegenerative diseases

By Blaylock R.L.

Integrative Medicine, Vol. 1, Iss. 3, 1999-06 ,pp. : 117-133

Elsevier

Access to resources Recommend Favorite

Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases

Recent Patents on CNS Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 96-111

Bentham Science Publishers

Access to resources Recommend Favorite

Familial Aggregation of Multiple Myeloma and Central Nervous System Diseases

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 37, Iss. 4, 1989-04 ,pp. : 303-309

John Wiley & Sons Inc

Access to resources Recommend Favorite